We are grateful for the many researchers and genetists who attended our workshop on August 23, 2012 at Harvard Medical School. Omixon’s CEO, Attila Berces, initiated the workshop with a presentation of how targeted analysis differs from whole genome analysis.

The participants were able to test Omixon Target during the workshop, and witness its speed and accuracy first hand. Users also enjoyed working with the Omixon browser and being able to effectively visualize large amounts of data.